Abstract:The aim of this study was to explore the clinical effect of montelukast sodium chewable tablets combined with inhaled budesonide in the treatment of pediatric asthma and its influence on inflammatory factors. One hundred and thirty-five asthmatic children were randomly divided into montelukast sodium group, budesonide group and combined group. Clinical symptoms, lung function, inflammatory factors and immune related indices of patients in each group were observed and recorded. After treatment, the times to disappearance of wheezes, dyspnea, asthma and hospital stay in the combined group were significantly shorter than those in the single-drug group (all p < 0.001). Forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), peak expiratory flow (PEF) were significantly higher than those before treatment, and in the combined group value were significantly higher than in the single-drug group in the same period (all p < 0.001). Tumor necrosis factor-alpha (TNF-alpha), interleukin-4 (IL- 4), IL-8 and hypersensitive C-reactive protein (hs-CRP) were significantly lower than before treatment, and the combined group was significantly lower than the single-drug group in the same period (all p < 0.05). The number of CD4(+) and CD3(+) cells in the combined group was significantly higher than that in the single-drug group, while the number of CD8(+) cells and the expression level of immune globulin E (IgE) were significantly lower (all p < 0.05). There was no difference in the incidence of adverse reactions between the groups during treatment (p > 0.05). Six months after treatment, the incidence of asthma in the combined group was significantly lower than that in the single-drug group (both p < 0.05). Montelukast sodium chewable tablets combined with inhaled budesonide can shorten the discomfort duration of asthmatic children and help them restore lung function. Moreover, it reduces the level of inflammatory factors and increases the resistance of children, which is worthy of further promotion and application.

Evaluation of relationship between montelukast and Churg-Strauss syndrome

Clinical Observation of Montelukast Prevention for Wheezing Infants and Young Children after Brochiolitis

Changes of Eosinophils in Bronchoalveolar Lavage Fluid of Asthma in Children and the Modulation Effect of Montelukast

Clinical Analysis of Eleven Cases with Churg-Strauss Syndrome

Effect of montelukast on the apoptosis of eosinophil in bronchoalveloar lavage fluid

Clinical Observation of Meng Lu Montelukast Sodium in the Treatment of Bronchiolitis

A Possible Case of Churg-Strauss Syndrome in a 9-Year-old Child.

Clinical efficacy analysis of methyl prednisolone combined with cyclophosphamide in treatment of Churg-Strauss syndrome

Clinical Analysis of Efficacy and Safety of Long Term Use of Montelukast Sodium in the Treatment of Patients with Chronic Cough and Negative Bronchial Provocation Test

Clinical observation of montelukast combined with antibiotics in the treatment of bronchiectasis

Evaluation of Functional Changes of Mast Cell Associated Mediators in the Induced Sputum from Patients with Gastroesophageal Reflux-Related Chronic Cough

The Efficacy of Montelukast on the Airway Hyperresponsiveness in Children with Asthmatic Bron-chitis

Montelukast for Postinfectious Cough: A Systematic Review of Randomized Controlled Trials.

Children with mild to moderate asthma efficacy of montelukast therapy

Treatment of Pediatric Mild Persistent Asthma with Low-Dose Budesonide Inhalation Suspension Vs.montelukast in China

Efficacy of montelukast sodium chewable tablets combined with inhaled budesonide in treating pediatric asthma and its effect on inflammatory factors.

The Efficacy of Montelukast Combined with Budesonide in Asthma Patients and the Combination’s Effects on the Patients’ Immune and Pulmonary Functions

Effects of montelukast in asthma patients combined with allergic rhinitis:meta-analysis

A Case Report And Literature Review Of Churg-Strauss Syndrome Presenting With Myocarditis

Effect of long time oral montelukast on pulmonary function and allergy index of patients with slight and moderate asthma

Efficacy and safety of Montelukast-Levocetirizine Combination Therapy in Combined Allergic Rhinitis and Asthma Syndrome: A Systematic Review and Meta-Analysis